Aminoglycosides

Aminoglycosides are a class of bactericidal antibiotics, exemplified by streptomycin and gentamicin, that bind the 30S ribosomal subunit and disrupt the fidelity of translation. They are particularly active against aerobic Gram-negative bacteria and are notable both for their potency and for their characteristic kidney and inner-ear toxicities.

Definition

Aminoglycosides are aminocyclitol antibiotics, typically aminosugars linked to an aminocyclitol ring, that bind the 16S ribosomal RNA of the 30S subunit and impair the accuracy of aminoacyl-tRNA decoding, producing a bactericidal effect chiefly against aerobic Gram-negative organisms.

Scope

This topic covers the chemistry, ribosomal target, mechanism of bactericidal action, the basis of selectivity, and the principal resistance mechanisms of the aminoglycoside class. It is a pharmacological reference entry; characteristic toxicities are described mechanistically rather than as monitoring or dosing guidance.

Core questions

• How do aminoglycosides bind the 30S subunit and corrupt translational fidelity?
• Why are aminoglycosides bactericidal rather than merely bacteriostatic?
• What explains their limited activity under anaerobic conditions?
• By what mechanisms do bacteria become resistant to aminoglycosides?

Key concepts

• 16S rRNA A-site (decoding site) binding
• Loss of translational fidelity and miscoding
• Concentration-dependent bactericidal action
• Oxygen-dependent uptake
• Aminoglycoside-modifying enzymes (acetyl-, phospho-, nucleotidyltransferases)
• 16S rRNA methyltransferase resistance
• Nephrotoxicity and ototoxicity

Mechanisms

Aminoglycosides bind the decoding (A) site of the 16S ribosomal RNA within the 30S subunit. Structural and biochemical studies localized this binding to a conserved internal loop of helix 44, where the drug stabilizes a conformation of the rRNA that the ribosome normally adopts only when a correct codon-anticodon pair is present. The ribosome is thereby misled into accepting near-cognate aminoacyl-tRNAs, reducing the fidelity of decoding and generating aberrant proteins; this loss of accuracy, together with effects on membrane integrity from the mistranslated products, underlies the bactericidal action that distinguishes aminoglycosides from many other ribosome-targeting drugs. Their entry into the cell requires an oxygen-dependent transport step, which helps explain their poor activity against anaerobes. Resistance arises mainly through enzymatic drug modification by acetyl-, phospho-, and nucleotidyltransferases, and through methylation of the 16S rRNA target site.

Clinical relevance

Aminoglycosides are an important option against serious aerobic Gram-negative infections, and their mechanism explains their bactericidal, concentration-dependent activity as well as their characteristic nephrotoxic and ototoxic potential. This entry presents the pharmacological basis of the class for reference and does not provide dosing, monitoring, or individualized treatment recommendations.

Evidence & guidelines

Class-level mechanism and resistance are summarized in comprehensive reviews and standard pharmacology texts, while the molecular basis of A-site binding is established by footprinting studies and by crystal structures of the 30S subunit in complex with aminoglycosides.

History

Streptomycin, isolated from Streptomyces griseus in 1943, was the first aminoglycoside and the first antibiotic effective against tuberculosis, and its discovery launched the class. Later members such as kanamycin, gentamicin, tobramycin, and amikacin extended the spectrum and addressed some resistance. The molecular interaction of aminoglycosides with 16S rRNA was mapped by chemical footprinting in the late 1980s and then visualized directly in ribosomal crystal structures around 2000.

Key figures

• Selman A. Waksman
• Harry F. Noller
• Venkatraman Ramakrishnan

Seminal works

• moazed-noller-1987
• carter-2000
• vakulenko-2003

Frequently asked questions

Why are aminoglycosides bactericidal when many ribosome-targeting antibiotics are only bacteriostatic?

Rather than simply stalling the ribosome, aminoglycosides corrupt the accuracy of translation so that the cell produces mistranslated proteins; these faulty products, including misfolded membrane proteins, contribute to cell death, giving the class a bactericidal rather than merely growth-arresting effect.

Why do aminoglycosides work poorly against anaerobic bacteria?

Their uptake into the bacterial cell depends on an oxygen-requiring transport process, so under anaerobic conditions too little drug reaches the ribosome to act, which is one reason the class is reserved largely for aerobic Gram-negative organisms.